Endoscopic therapies for the prevention and treatment of early esophageal neoplasia

References

• Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N. Engl. J. Med.349(22), 2117–2127 (2003).
   PubMed Web of Science ®Google Scholar
• Moraca RJ, Low DE. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch. Surg.141(6), 545–549 (2006).
   PubMedGoogle Scholar
• Alvarez HL, Pouw RE, van Vilsteren FG et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy42(12), 1030–1036 (2010).
   PubMedGoogle Scholar
• Liu L, Hofstetter WL, Rashid A et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am. J. Surg. Pathol.29(8), 1079–1085 (2005).
   PubMed Web of Science ®Google Scholar
• Sepesi B, Watson TJ, Zhou D et al. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J. Am. Coll. Surg.210(4), 418–427 (2010).
   PubMedGoogle Scholar
• Westerterp M, Koppert LB, Buskens CJ et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro–esophageal junction. Virchows Arch.446(5), 497–504 (2005).
   PubMed Web of Science ®Google Scholar
• Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, Ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest. Endosc.60(5), 703–710 (2004).
   PubMed Web of Science ®Google Scholar
• Eguchi T, Nakanishi Y, Shimoda T et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod. Pathol.19(3), 475–480 (2006).
   PubMed Web of Science ®Google Scholar
• Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis. Esophagus13(2), 125–129 (2000).
   PubMed Web of Science ®Google Scholar
• Fujita H, Sueyoshi S, Yamana H et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J. Surg.25(4), 424–431 (2001).
   PubMed Web of Science ®Google Scholar
• Shimada H, Nabeya Y, Matsubara H et al. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am.J. Surg.191(2), 250–254 (2006).
   PubMed Web of Science ®Google Scholar
• Manner H, May A, Pech O et al. Early Barrett’s carcinoma with ‘low-risk’ submucosal invasion: long-term results of endoscopic resection with a curative intent. Am. J. Gastroenterol.103(10), 2589–2597 (2008).
   PubMed Web of Science ®Google Scholar
• Semlitsch T, Jeitler K, Schoefl R et al. A systematic review of the evidence for radiofrequency ablation for Barrett‘s esophagus. Surg. Endosc.24(12), 2935–2943 (2010).
   PubMedGoogle Scholar
• May A, Gunter E, Roth F et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut53(5), 634–640 (2004).
   PubMed Web of Science ®Google Scholar
• Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest. Endosc.44(1), 8–14 (1996).
   PubMed Web of Science ®Google Scholar
• Uno Y, Munakata A. The non-lifting sign of invasive colon cancer. Gastrointest. Endosc.40(4), 485–489 (1994).
   PubMed Web of Science ®Google Scholar
• Longcroft-Wheaton G, Duku M, Mead R, Poller D, Bhandari P. Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett’s esophagus. Clin. Gastroenterol. Hepatol.8(10), 843–847 (2010).
   PubMed Web of Science ®Google Scholar
• Basford P, Longcroft-Wheaton G, Bhandari P. Squamous dysplasia of the oesophagus: Use of advanced imaging techniques and chromoendoscopy. Presented at: British Society of Gastroenterology Annual Meeting. Birmingham, UK, 14–17 March 2011.
   Google Scholar
• Kara MA, Peters FP, Rosmolen WD et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a prospective randomized crossover study. Endoscopy37(10), 929–936 (2005).
   PubMed Web of Science ®Google Scholar
• Dunbar KB, Okolo P III, Montgomery E, Canto MI. Confocal laser endomicroscopy in Barrett’s esophagus and endoscopically inapparent Barrett’s neoplasia: a prospective, randomized, double-blind, controlled, crossover trial. Gastrointest. Endosc.70(4), 645–654 (2009).
   PubMed Web of Science ®Google Scholar
• Bhandari P, Green S, Hamanaka H et al. Use of gascon and pronase either as a pre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: a prospective, randomized, controlled, blinded trial. Scand. J. Gastroenterol.45(3), 357–361 (2010).
   PubMed Web of Science ®Google Scholar
• Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagus. Gastrointest. Endosc.62(1), 16–23 (2005).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Heldoorn N, Herrero LA et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest. Endosc.73(4), 662–668 (2011).
   PubMedGoogle Scholar
• Young PE, Gentry AB, Acosta RD, Greenwald BD, Riddle M. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin. Gastroenterol. Hepatol.8(12), 1037–1041 (2010).
   PubMed Web of Science ®Google Scholar
• May A, Gossner L, Pech O et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach. Eur. J. Gastroenterol. Hepatol.14(10), 1085–1091 (2002).
   PubMed Web of Science ®Google Scholar
• Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat. Res.589(1), 47–65 (2005).
   PubMed Web of Science ®Google Scholar
• Dvorak K, Payne CM, Chavarria M et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus. Gut56(6), 763–771 (2007).
   PubMed Web of Science ®Google Scholar
• Galipeau PC, Cowan DS, Sanchez CA et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett’s esophagus. Proc. Natl Acad. Sci. USA93(14), 7081–7084 (1996).
   PubMed Web of Science ®Google Scholar
• Playford RJ. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus. Gut55(4), 442 (2006).
   PubMedGoogle Scholar
• Pesko P, Rakic S, Milicevic M, Bulajic P, Gerzic Z. Prevalence and clinicopathologic features of multiple squamous cell carcinoma of the esophagus. Cancer73(11), 2687–2690 (1994).
   PubMedGoogle Scholar
• Morita M, Kuwano H, Ohno S et al. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int. J. Cancer58(2), 207–210 (1994).
   PubMed Web of Science ®Google Scholar
• Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am. J Pathol.161(3), 1051–1060 (2002).
   PubMed Web of Science ®Google Scholar
• Califano J, Leong PL, Koch WM, Eisenberger CF, Sidransky D, Westra WH. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin. Cancer Res.5(7), 1862–1867 (1999).
   PubMed Web of Science ®Google Scholar
• Crockett SD, Lippmann QK, Dellon ES, Shaheen NJ. Health-related quality of life in patients with Barrett’s esophagus: a systematic review. Clin. Gastroenterol. Hepatol.7(6), 613–623 (2009).
   PubMedGoogle Scholar
• Deschamps C, Nichols FC III, Cassivi SD, Allen MS, Pairolero PC. Long-term function and quality of life after esophageal resection for cancer and Barrett’s. Surg. Clin. North Am.85(3), 649–656 (2005).
   PubMed Web of Science ®Google Scholar
• Skipworth RJ, Parks RW, Stephens NA et al. The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982–2003. Eur. J. Surg. Oncol.36(2), 141–147 (2010).
   PubMedGoogle Scholar
• Wouters MW, Karim-Kos HE, Le CS et al. Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann. Surg. Oncol.16(7), 1789–1798 (2009).
   PubMed Web of Science ®Google Scholar
• Dresner SM, Griffin SM, Wayman J, Bennett MK, Hayes N, Raimes SA. Human model of duodenogastro-oesophageal reflux in the development of Barrett’s metaplasia. Br. J. Surg.90(9), 1120–1128 (2003).
   PubMedGoogle Scholar
• Hamilton SR, Yardley JH. Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology72(4 Pt 1), 669–675 (1977).
   PubMedGoogle Scholar
• Tseng EE, Wu TT, Yeo CJ, Heitmiller RF. Barrett’s esophagus with high grade dysplasia: surgical results and long-term outcome – an update. J. Gastrointest. Surg.7(2), 164–170 (2003).
   PubMedGoogle Scholar
• Chang LC, Oelschlager BK, Quiroga E et al. Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett’s esophagus. J. Gastrointest. Surg.10(3), 341–346 (2006).
   PubMedGoogle Scholar
• Mirnezami R, Rohatgi A, Sutcliffe RP, Hamouda A, Mason RC. Transhiatal oesophagectomy: treatment of choice for high-grade dysplasia. Eur. J. Cardiothorac. Surg.36(2), 364–367 (2009).
   PubMedGoogle Scholar
• Peyre CG, DeMeester SR, Rizzetto C et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia. Ann. Surg.246(4), 665–671 (2007).
   PubMed Web of Science ®Google Scholar
• Wani S, Mathur SC, Curvers WL et al. Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett’s dysplasia. Clin. Gastroenterol. Hepatol.8(9), 783–788 (2010).
   PubMed Web of Science ®Google Scholar
• Mino-Kenudson M, Ban S, Ohana M et al. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy. Am. J. Surg. Pathol.31(3), 403–409 (2007).
   PubMed Web of Science ®Google Scholar
• Bennett C, Wang Y, Pan T. Endoscopic mucosal resection for early gastric cancer. Cochrane Database Syst. Rev. (4), CD004276 (2009).
   Google Scholar
• Rees JR, Lao-Sirieix P, Wong A, Fitzgerald RC. Treatment for Barrett’s oesophagus. Cochrane Database Syst. Rev. (1), CD004060 (2010).
   Google Scholar
• Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest. Endosc.39(1), 58–62 (1993).
   PubMed Web of Science ®Google Scholar
• Masuda K, Fujisaki J, Suzuki H, Okuwaki S, Miyamoto K. Endoscopic mucosal resection using ligating device (EMRL). Dig. Endosc.5, 1215–1219 (1993).
   Google Scholar
• May A, Gossner L, Behrens A et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest. Endosc.58(2), 167–175 (2003).
   PubMed Web of Science ®Google Scholar
• Suzuki H. Endoscopic mucosal resection using ligating device for early gastric cancer. Gastrointest. Endosc. Clin. N. Am.11(3), 511–518 (2001).
   PubMedGoogle Scholar
• Oyama T, Tomori A, Hotta K et al. Endoscopic submucosal dissection of early esophageal cancer. Clin. Gastroenterol. Hepatol.3(7 Suppl. 1), S67–S70 (2005).
   PubMedGoogle Scholar
• Yokoi C, Gotoda T, Hamanaka H, Oda I. Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection. Gastrointest. Endosc.64(2), 212–218 (2006).
   PubMed Web of Science ®Google Scholar
• Alvarez HL, Pouw RE, van Vilsteren FG et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy43(3), 177–183 (2011).
   PubMedGoogle Scholar
• Narahara H, Iishi H, Tatsuta M et al. Effectiveness of endoscopic mucosal resection with submucosal saline injection technique for superficial squamous carcinomas of the esophagus. Gastrointest. Endosc.52(6), 730–734 (2000).
   PubMedGoogle Scholar
• Tani M, Sakai P, Kondo H. Endoscopic mucosal resection of superficial cancer in the stomach using the cap technique. Endoscopy35(4), 348–355 (2003).
   PubMedGoogle Scholar
• Pech O, Behrens A, May A et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut57(9), 1200–1206 (2008).
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Kawata H, Sunada K et al. Success rate of curative endoscopic mucosal resection with circumferential mucosal incision assisted by submucosal injection of sodium hyaluronate. Gastrointest. Endosc.56(4), 507–512 (2002).
   PubMedGoogle Scholar
• Repici A, Hassan C, Carlino A et al. Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective western series. Gastrointest. Endosc.71(4), 715–721 (2010).
   PubMedGoogle Scholar
• Fukami N, Yen RD, Brauer BC, Shah RJ. Endoscopic submucosal dissection for barrett’s high grade dysplasia or early adenocarcinoma: a U.S. single centre’s experience. Gastrointest. Endosc.73(4), AB114 (2011).
   Google Scholar
• Smith CD, Bejarano PA, Melvin WS, Patti MG, Muthusamy R, Dunkin BJ. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg. Endosc.21(4), 560–569 (2007).
   PubMedGoogle Scholar
• Bumgarner J, Panjehpour M, Long MD et al. Comparison of catheter-based radiofrequency ablation and photodynamic therapy for Barrett’s oesophagus. Digestive Diseases Week134(4 Suppl.1), A436 (2008).
   Google Scholar
• Lyday WD, Corbett FS, Kuperman DA et al. Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy42(4), 272–278 (2010).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Gondrie JJ, Curvers WL, Sondermeijer CM, Ten Kate FJ, Bergman JJ. Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report. Gastrointest. Endosc.68(3), 537–541 (2008).
   PubMedGoogle Scholar
• van Vilsteren FG, Alvarez HL, Pouw RE et al. Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma. Endoscopy43(4), 282–290 (2011).
   PubMedGoogle Scholar
• Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N. Engl. J. Med.360(22), 2277–2288 (2009).
   PubMed Web of Science ®Google Scholar
• Bulsiewicz WJ, Shaheen NJ. The role of radiofrequency ablation in the management of Barrett’s esophagus. Gastrointest. Endosc. Clin. N. Am.21(1), 95–109 (2011).
   PubMedGoogle Scholar
• Boger PC, Turner D, Roderick P, Patel P. A UK-based cost–utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett’s oesophagus. Aliment. Pharmacol. Ther.32(11–12), 1332–1342 (2010).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Gondrie JJ, Rygiel AM et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett’s esophagus containing neoplasia. Am. J. Gastroenterol.104(6), 1366–1373 (2009).
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Peery AF, Overholt BF et al. Biopsy depth after radiofrequency ablation of dysplastic Barrett’s esophagus. Gastrointest. Endosc.72(3), 490–496 (2010).
   PubMedGoogle Scholar
• Pouw RE, Wirths K, Eisendrath P et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin. Gastroenterol. Hepatol.8(1), 23–29 (2010).
   PubMed Web of Science ®Google Scholar
• Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett’s esophagus. Gastrointest. Endosc.42(1), 59–63 (1995).
   PubMed Web of Science ®Google Scholar
• Gomer CJ, Dougherty TJ. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res.39(1), 146–151 (1979).
   PubMed Web of Science ®Google Scholar
• Gossner L, Stolte M, Sroka R et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid. Gastroenterology114(3), 448–455 (1998).
   PubMed Web of Science ®Google Scholar
• Pech O, Gossner L, May A et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia. Gastrointest. Endosc.62(1), 24–30 (2005).
   PubMed Web of Science ®Google Scholar
• Overholt BF, Lightdale CJ, Wang KK et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized Phase III trial. Gastrointest. Endosc.62(4), 488–498 (2005).
   PubMed Web of Science ®Google Scholar
• Ragunath K, Krasner N, Raman VS, Haqqani MT, Phillips CJ, Cheung I. Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost–effectiveness. Scand. J. Gastroenterol.40(7), 750–758 (2005).
   PubMed Web of Science ®Google Scholar
• Van Laethem JL, Jagodzinski R, Peny MO, Cremer M, Deviere J. Argon plasma coagulation in the treatment of Barrett’s high-grade dysplasia and in situ adenocarcinoma. Endoscopy33(3), 257–261 (2001).
   PubMedGoogle Scholar
• Attwood SE, Lewis CJ, Caplin S, Hemming K, Armstrong G. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s esophagus. Clin. Gastroenterol. Hepatol.1(4), 258–263 (2003).
   PubMed Web of Science ®Google Scholar
• Manner H, Rabenstein T, Braun K et al. What should we do with the remainder of the Barrett’s segment after endoscopic resection of early Barrett’s cancer? Intermediate results of the first prospective-randomized trial on the APC ablation of residual Barrett’s mucosa with concomitant esomeprazole therapy versus surveillance without ablation after ER of early Barrett’s cancer. Gastrointest. Endosc.71(5), AB175 (2010).
   Google Scholar
• Greenwald BD, Dumot JA, Abrams JA et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest. Endosc.71(4), 686–693 (2010).
   PubMedGoogle Scholar
• Shaheen NJ, Greenwald BD, Peery AF et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett’s esophagus with high-grade dysplasia. Gastrointest. Endosc.71(4), 680–685 (2010).
   PubMed Web of Science ®Google Scholar
• Odze RD, Lauwers GY. Histopathology of Barrett’s esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy40(12), 1008–1015 (2008).
   PubMedGoogle Scholar
• Barham CP, Jones RL, Biddlestone LR, Hardwick RH, Shepherd NA, Barr H. Photothermal laser ablation of Barrett’s oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut41(3), 281–284 (1997).
   PubMed Web of Science ®Google Scholar
• Bronner MP, Overholt BF, Taylor SL et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett’s esophagus with high-grade dysplasia. Gastroenterology136(1), 56–64 (2009).
   PubMed Web of Science ®Google Scholar
• Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest. Endosc.58(2), 183–188 (2003).
   PubMed Web of Science ®Google Scholar
• Hornick JL, Mino-Kenudson M, Lauwers GY, Liu W, Goyal R, Odze RD. Buried Barrett’s epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am. J. Gastroenterol.103(1), 38–47 (2008).
   PubMed Web of Science ®Google Scholar
• Hornick JL, Blount PL, Sanchez CA et al. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett’s esophagus. Am. J. Surg. Pathol.29(3), 372–380 (2005).
   PubMed Web of Science ®Google Scholar
• Van Laethem JL, Peny MO, Salmon I, Cremer M, Deviere J. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus. Gut46(4), 574–577 (2000).
   PubMed Web of Science ®Google Scholar
• Sampliner RE, Fass R. Partial regression of Barrett’s esophagus – an inadequate endpoint. Am. J. Gastroenterol.88(12), 2092–2094 (1993).
   PubMedGoogle Scholar
• Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of barrett’s esophagus: a systematic review. Am. J. Gastroenterol. DOI: 10.1038/ajg.2011.255 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Katada C, Muto M, Manabe T, Boku N, Ohtsu A, Yoshida S. Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest. Endosc.57(2), 165–169 (2003).
   PubMed Web of Science ®Google Scholar
• Wolfsen HC, Crook JE, Krishna M et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett’s esophagus. Gastroenterology135(1), 24–31 (2008).
   PubMed Web of Science ®Google Scholar
• Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Lutzke LS, Borkenhagen LS. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. Gastrointest. Endosc.65(1), 60–66 (2007).
   PubMed Web of Science ®Google Scholar
• Vassiliou MC, von RD, Wiener DC, Gordon SR, Rothstein RI. Treatment of ultralong-segment Barrett’s using focal and balloon-based radiofrequency ablation. Surg. Endosc.24(4), 786–791 (2010).
   PubMed Web of Science ®Google Scholar
• van Vilsteren FG, Pouw RE, Seewald S et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett’s oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut60(6), 765–773 (2011).
   PubMed Web of Science ®Google Scholar
• Goldblum JR. Barrett’s esophagus and Barrett’s-related dysplasia. Mod. Pathol.16(4), 316–324 (2003).
   PubMedGoogle Scholar
• Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol.8(3), 235–244 (2010).
   PubMed Web of Science ®Google Scholar
• de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett’s oesophagus: a Dutch nationwide cohort study. Gut59(8), 1030–1036 (2010).
   PubMed Web of Science ®Google Scholar
• Wani S. Population-based estimates of cancer and mortality in Barrett’s esophagus: implications for the future. Clin. Gastroenterol. Hepatol.9(9), 723–724 (2011).
   PubMedGoogle Scholar
• Chang EY, Morris CD, Seltman AK et al. The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. Ann. Surg.246(1), 11–21 (2007).
   PubMed Web of Science ®Google Scholar
• Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy42(10), 781–789 (2010).
   PubMed Web of Science ®Google Scholar
• Johnston MH, Eastone JA, Horwhat JD, Cartledge J, Mathews JS, Foggy JR. Cryoablation of Barrett’s esophagus: a pilot study. Gastrointest. Endosc.62(6), 842–848 (2005).
   PubMed Web of Science ®Google Scholar
• Curvers WL, Ten Kate FJ, Krishnadath KK et al. Low-grade dysplasia in Barrett’s esophagus: overdiagnosed and underestimated. Am. J. Gastroenterol.105(7), 1523–1530 (2010).
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology96(5 Pt 1), 1249–1256 (1989).
   PubMed Web of Science ®Google Scholar
• Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin. Gastroenterol. Hepatol.4(5), 566–572 (2006).
   PubMed Web of Science ®Google Scholar
• Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression. Am. J. Gastroenterol.95(12), 3383–3387 (2000).
   PubMed Web of Science ®Google Scholar
• Wani S, Falk GW, Post J et al. Risk factors for progression of low-grade dysplasia in patients with Barrett’s esophagus. Gastroenterology141(4), 1179–1186 (2011).
   PubMedGoogle Scholar
• Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am. J. Gastroenterol.103(3), 788–797 (2008).
   PubMed Web of Science ®Google Scholar
• Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology105(1), 40–50 (1993).
   PubMed Web of Science ®Google Scholar
• Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett‘s esophagus. Ann. Surg.232(6), 733–742 (2000).
   PubMed Web of Science ®Google Scholar
• Bennett C, Green S, Barr H et al. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett’s oesophagus. Cochrane Database Syst. Rev. (5), CD007334 (2010).
   Google Scholar
• Yachimski P, Nishioka NS, Richards E, Hur C. Treatment of Barrett’s esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin. Gastroenterol. Hepatol.6(11), 1206–1211 (2008).
   PubMed Web of Science ®Google Scholar
• Konda VJ, Ross AS, Ferguson MK et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett’s esophagus overestimated? Clin. Gastroenterol. Hepatol.6(2), 159–164 (2008).
   PubMed Web of Science ®Google Scholar
• Schnell TG, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Gastroenterology120(7), 1607–1619 (2001).
   PubMed Web of Science ®Google Scholar
• Curvers WL, Bansal A, Sharma P, Bergman JJ. Endoscopic work-up of early Barrett’s neoplasia. Endoscopy40(12), 1000–1007 (2008).
   PubMedGoogle Scholar
• Pech O, May A, Gossner L. The effect of ablation of non-neoplastic Barrett’s epithelium of recurrence rate of high grade dysplasia and early Barrett’s cancer after endoscopic therapy: an analysis of 219 patients. Digestive Diseases Week19, 15 (2007).
   Google Scholar
• Prasad GA, Wang KK, Buttar NS et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology132(4), 1226–1233 (2007).
   PubMed Web of Science ®Google Scholar
• Chennat J, Konda VJ, Ross AS et al. Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma – an American single-center experience. Am. J. Gastroenterol.104(11), 2684–2692 (2009).
   PubMed Web of Science ®Google Scholar
• Pouw RE, Seewald S, Gondrie JJ et al. Stepwise radical endoscopic resection for eradication of Barrett’s oesophagus with early neoplasia in a cohort of 169 patients. Gut59(9), 1169–1177 (2010).
   PubMed Web of Science ®Google Scholar
• Overholt BF, Wang KK, Burdick JS et al. Five-year efficacy and safety of photodynamic therapy with photofrin in Barrett’s high-grade dysplasia. Gastrointest. Endosc.66(3), 460–468 (2007).
   PubMed Web of Science ®Google Scholar
• Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology108(2), 337–344 (1995).
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Peery AF, Hawes RH et al. Quality of life following radiofrequency ablation of dysplastic Barrett’s esophagus. Endoscopy42(10), 790–799 (2010).
   PubMed Web of Science ®Google Scholar
• Pech O, May A, Manner H, Pohl H, Ell C. Endoscopic resection in 953 patients with mucosal Barrett’s cancer. Gastrointest. Endosc.73(4), AB146 (2011).
   Google Scholar
• Takeshita K, Tani M, Inoue H et al. Endoscopic treatment of early oesophageal or gastric cancer. Gut40(1), 123–127 (1997).
   PubMed Web of Science ®Google Scholar
• Pech O, May A, Gossner L et al. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy39(1), 30–35 (2007).
   PubMed Web of Science ®Google Scholar
• Isono K. Guidelines for clinical and pathological studies on carcinoma of the esophagus. Esophagus1(2), 61–88 (1997).
   Google Scholar
• Higuchi K, Tanabe S, Koizumi W et al. Expansion of the indications for endoscopic mucosal resection in patients with superficial esophageal carcinoma. Endoscopy39(1), 36–40 (2007).
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest. Endosc.56(3), 387–390 (2002).
   PubMedGoogle Scholar
• Ota M, Ide H, Hayashi K et al. Multimodality treatments with endoscopic mucosal resection of esophageal squamous cell carcinoma with submucosal invasion. Surg. Endosc.17(9), 1429–1433 (2003).
   PubMedGoogle Scholar
• Shimizu Y, Kato M, Yamamoto J et al. EMR combined with chemoradiotherapy: a novel treatment for superficial esophageal squamous-cell carcinoma. Gastrointest. Endosc.59(2), 199–204 (2004).
   PubMed Web of Science ®Google Scholar
• Fujishiro M, Yahagi N, Kakushima N et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin. Gastroenterol. Hepatol.4(6), 688–694 (2006).
   PubMed Web of Science ®Google Scholar
• Tanaka T, Matono S, Nagano T et al. Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus. Gastrointest. Endosc.73(1), 1–6 (2011).
   PubMedGoogle Scholar
• Dunn JM, Thorpe S, Novelli MR, Bown SG, Lovat L. Radiofrequency ablation for the treatment of squamous high grade dysplasia of the oesophagus – first reported series. Gastrointest. Endosc.69(5), AB255 (2009).
   Google Scholar
• Akhtar K, Byrne JP, Bancewicz J, Attwood SE. Argon beam plasma coagulation in the management of cancers of the esophagus and stomach. Surg. Endosc.14(12), 1127–1130 (2000).
   PubMedGoogle Scholar
• Schembre DB, Huang JL, Lin OS, Cantone N, Low DE. Treatment of Barrett’s esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest. Endosc.67(4), 595–601 (2008).
   PubMed Web of Science ®Google Scholar
• Weston AP, Banerjee SK, Sharma P, Tran TM, Richards R, Cherian R. p53 protein overexpression in low grade dysplasia (LGD) in Barrett’s esophagus: immunohistochemical marker predictive of progression. Am. J. Gastroenterol.96(5), 1355–1362 (2001).
   PubMed Web of Science ®Google Scholar
• Morales CP, Souza RF, Spechler SJ. Hallmarks of cancer progression in Barrett’s oesophagus. Lancet360(9345), 1587–1589 (2002).
   PubMed Web of Science ®Google Scholar
• Chao DL, Sanchez CA, Galipeau PC et al. Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett’s esophagus: a long-term prospective study. Clin. Cancer Res.14(21), 6988–6995 (2008).
   PubMed Web of Science ®Google Scholar
• Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ. Predictors of progression in Barrett’s esophagus III: baseline flow cytometric variables. Am. J. Gastroenterol.96(11), 3071–3083 (2001).
   PubMed Web of Science ®Google Scholar
• Ferraris R, Bonelli L, Conio M, Fracchia M, Lapertosa G, Aste H. Incidence of Barrett’s adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE). Eur. J. Gastroenterol. Hepatol.9(9), 881–885 (1997).
   PubMed Web of Science ®Google Scholar
• Abe N, Mori T, Izumisato Y et al. Successful treatment of an undifferentiated early stage gastric cancer by combined en bloc EMR and laparoscopic regional lymphadenectomy. Gastrointest. Endosc.57(7), 972–975 (2003).
   PubMedGoogle Scholar
• Ikeda K, Mosse CA, Park PO et al. Endoscopic full-thickness resection: circumferential cutting method. Gastrointest. Endosc.64(1), 82–89 (2006).
   PubMed Web of Science ®Google Scholar
• Jankowski J, Vakil N, Ferguson M et al. Barrett’s dysplasia cancer task force – BAD CAT: a global, multidisciplinary, consensus on the management of high grade dysplasia and early mucosal cancer in Barrett’s esophagus. Digestive Disease Week140, 1 (2011).
   Google Scholar